Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Transplantation of Fas-deficient or wild-type neural stem/progenitor cells (NPCs) is equally efficient in treating experimental autoimmune encephalomyelitis (EAE).
Retinal nerve fiber layer thickness and thalamus pathology in multiple sclerosis patients.
Glutathione in multiple sclerosis: More than just an antioxidant?
More than just multiple sclerosis.
Characterisation of uveitis in association with multiple sclerosis.
Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.
Perceived changes and minimum clinically important difference of the Neurological Fatigue Index for multiple sclerosis (NFI-MS).
Relationships among physical inactivity, deconditioning, and walking impairment in persons with multiple sclerosis.
TNF-alpha Production by Peripheral Blood Monocytes in Multiple Sclerosis Patients and Healthy Controls.
Pharmacogenomics of interferon-β in multiple sclerosis: What has been accomplished and how can we ensure future progress?
Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitors Remyelinate the Brain and Rescue Behavioral Deficits following Radiation.
Italian validation of the 12-item multiple sclerosis walking scale.
Alemtuzumab (LEMTRADA) and multiple sclerosis. Biased evaluation, evidence of serious risks.
A Randomized Trial Evaluating Various Administration Routes of Natalizumab in Multiple Sclerosis.
CD226 Gly307Ser association with multiple autoimmune diseases: A meta-analysis.
Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis.
Clostridia as agents of zoonotic disease.
Higher burden of migraine compared to other neurological conditions: results from a cross-sectional study.
Social support, depression, and physical disability: Age and diagnostic group effects.
Responsibilities of Health Care Professionals in Counseling and Educating Patients With Incurable Neurological Diseases Regarding "Stem Cell Tourism": Caveat Emptor.
2015 Multiple Sclerosis Experts Summit.
Non-Significant Associations Between Measures of Inhibitory Control and Walking While Thinking in Persons with Multiple Sclerosis.
Predictors of disability worsening in clinically isolated syndrome.
Burden and quality of life in caregivers of persons with multiple sclerosis.
Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
293
294
295
296
297
298
299
300
301
…
next ›
last »